No phaseRecruiting
A Study of Freezing and Reimplanting a Patient's Own Ovarian Tissue to Preserve Future Fertility
Ovarian Tissue Cryopreservation and Autologous Transplantation for Fertility Preservation in Young Patients with Cancer or Immune Diseases and in Patients with Premature Ovarian Insufficiency - Ovarian Tissue Cryopreservation and Autologous Transplantation Study
- Sponsor
- Hokkaido University
- Enrolment
- 150 planned
- Conditions
- Malignant neoplasms and immune diseases associated with a high risk of fertility impairment, and premature ovarian insufficiency
- Interventions
- Within 60 days after enrollment, laparoscopic unilateral oophorectomy will, in principle, be performed under general anesthesia
- Ages
- children, adults
- Registry
- UMIN000062447
Full record on UMIN-CTRSource: WHO ICTRP, processed 14 September 2026
Primary outcomes
- Proportion of participants who deliver a live-born infant among those who undergo autologous ovarian tissue transplantation, assessed through the end of follow-up.
History
Study completion expected
Last registry update
Registered